CIK: 0001792206 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $120,193 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALMS | Alumis Inc | 5,779,348 | $45,426 | 37.8% | $13.19 | -24.0% | COM | 022307102 |
| HIMS | Hims & Hers Health, Inc. | 939,860 | $22,726 | 18.9% | $8.41 | +194.7% | COM CL A | 433000106 |
| CGON | CG Oncology, Inc. | 692,550 | $19,862 | 16.5% | $40.84 | -16.2% | COM | 156944100 |
| IRON | Disc Medicine, Inc. | 299,069 | $18,961 | 15.8% | $46.85 | +23.5% | COM | 254604101 |
| CGEM | Cullinan Therapeutics Inc | 657,905 | $8,013 | 6.7% | $21.29 | -32.5% | COM | 230031106 |
| — | Lyell Immunopharma Inc | 8,133,047 | $5,205 | 4.3% | $0.64 | — | COM | 55083R104 |